Thrombocytopenia and carcinoma.

Area of Science:

• Oncology
• Hematology
• Immunology

Background:

• Thrombocytopenia, a condition characterized by low platelet counts, can arise from various causes.
• Lung carcinoma is a significant malignancy with diverse clinical presentations.
• Immune mechanisms can lead to hematological disorders, including thrombocytopenia.

Purpose of the Study:

• To describe two cases of lung carcinoma presenting with severe thrombocytopenia.
• To investigate the potential mechanisms underlying thrombocytopenia in these patients.
• To suggest a link between thrombocytopenia in older adults and potential occult lung carcinoma.

Main Methods:

• Case report detailing clinical presentation, diagnostic workup, and treatment of two patients.
• Differential diagnosis of thrombocytopenia, excluding marrow infiltration and consumption coagulopathy.
• Review of literature regarding immune-mediated thrombocytopenia and its association with malignancy.

Main Results:

• Two patients with lung carcinoma and severe thrombocytopenia were identified.
• Thrombocytopenia was attributed to an immune mechanism rather than direct tumor effects.
• No evidence of marrow replacement by carcinoma or consumption coagulopathy was found.

Conclusions:

• Severe thrombocytopenia in elderly patients may be an early sign of undiagnosed lung carcinoma.
• Immune-mediated thrombocytopenia should be considered in the differential diagnosis of older patients with low platelet counts.
• Further investigation for occult malignancy is warranted in this patient population.